Healthcare Industry News Weekly Wrap-Up: October 13, 2022
// Biotech and Pharma Therapeutics Stalicla signs licence deal for Evgen Pharma’s lead asset SFX-01 October 11, 2022 / Stalicla / Licensing Deal More than a year after Eli Lilly received a subpoena centered on quality control snafus and alleged...